New insights into the second generation antihistamines

被引:63
作者
Walsh, GM [1 ]
Annunziato, L
Frossard, N
Knol, K
Levander, S
Nicolas, JM
Taglialatela, M
Tharp, MD
Tillement, JP
Timmerman, H
机构
[1] Univ Aberdeen, Inst Med Sci, Dept Med & Therapeut, Aberdeen, Scotland
[2] Univ Naples Federico II, Sch Med, Dept Neurosci, Naples, Italy
[3] Univ Strasbourg, Strasbourg, France
[4] Univ Groningen Hosp, Dept Paediat, Groningen, Netherlands
[5] Lund Univ, Dept Psychiat, Malmo, Sweden
[6] UCB Bioprod SA, Pharma Sector, Dept Prod Safety & Metab, Brussels, Belgium
[7] Rush Presbyterian St Lukes Med Ctr, Dept Dermatol, Chicago, IL 60612 USA
[8] Univ Paris 07, Dept Pharmacol, Paris, France
[9] Vrije Univ Amsterdam, Leiden Amsterdam Ctr Drug Res, Amsterdam, Netherlands
关键词
D O I
10.2165/00003495-200161020-00006
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Second generation antihistamines are recognised as being highly effective treatments for allergy-based disease and are among the most frequently prescribed and safest drugs in the world. However, consideration of the therapeutic index or the benefit/risk ratio of the H-1 receptor antagonists is of paramount importance when prescribing this class of compounds as they are used to treat non-life threatening conditions. Then are many second generation antihistamines available and at first examination these appear to be comparable in terms of safety and efficacy. However, the newer antihistamines in fact represent a hererogeneous group of compounds, having markedly differing chemical structures, adverse effects, half-life, tissue distribution and metabolism, spectrum of antihistaminic properties, and varying degrees of anti-inflammatory effects. With regard to the latter, there is growing awareness that some of these compounds might represent useful adjunct medications in asthma therapy. In terms of safety issues, the current second generation grouping includes compounds with proven cardiotoxic effects and others with the potential for adverse drug interactions, Moreover, some of the second generation H1 antagonists have given cause for concern regarding their potential to cause a degree of somnolence in some individuals. It can be argued, therefore, that the present second generation grouping is too large and indistinct since this was based primarily on the concept of separating the first generation sedating compounds from nonsedating H1 antagonists. Although it is too early to talk about a third generation grouping of antihistamines, future membership of such a classification could be based on a low volume of distribution coupled with a lack of sedating effects, drug interactions and cardiotoxicity.
引用
收藏
页码:207 / 236
页数:30
相关论文
共 309 条
[1]   Evaluation of cetirizine in patients with allergic rhinitis and perennial asthma [J].
Aaronson, DW .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 1996, 76 (05) :440-446
[2]   Effect of fexofenadine on eosinophil-induced changes in epithelial permeability and cytokine release from nasal epithelial cells of patients with seasonal allergic rhinitis [J].
Abdelaziz, MM ;
Devalia, JL ;
Khair, OA ;
Bayram, H ;
Prior, AJ ;
Davies, RJ .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1998, 101 (03) :410-420
[3]  
AFFRIME MB, 1993, ALLERGY S16, V47, P29
[4]  
AGARWAL D, 2000, J ALLERGY CLIN IMMUN, P105
[5]   SELECTIVE DISPLACEMENT OF [H-3] MEPYRAMINE FROM PERIPHERAL VS CENTRAL-NERVOUS-SYSTEM RECEPTORS BY LORATADINE, A NONSEDATING ANTIHISTAMINE [J].
AHN, HS ;
BARNETT, A .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 127 (1-2) :153-155
[6]   SPONTANEOUS HISTAMINE-RELEASE AND HISTAMINE CONTENT IN NORMAL SUBJECTS AND SUBJECTS WITH ASTHMA [J].
AKAGI, K ;
TOWNLEY, RG .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1989, 83 (04) :742-749
[7]   EFFECTS OF AZELASTINE ON NEUTROPHIL CHEMOTAXIS, PHAGOCYTOSIS AND OXYGEN RADICAL GENERATION [J].
AKAMATSU, H ;
MIYACHI, Y ;
ASADA, Y ;
NIWA, Y .
JAPANESE JOURNAL OF PHARMACOLOGY, 1991, 57 (04) :583-589
[8]   CETIRIZINE VS ASTEMIZOLE IN THE TREATMENT OF CHRONIC IDIOPATHIC URTICARIA [J].
ALOMAR, A ;
DELACUADRA, J ;
FERNANDEZ, J .
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1990, 18 (05) :358-365
[9]  
AMON S, 2000, J ALLERGY CLIN IMMUN, P105
[10]   SUPPRESSIVE EFFECT OF LORATADINE ON ALLERGEN-INDUCED HISTAMINE-RELEASE IN THE NOSE [J].
ANDERSSON, M ;
NOLTE, H ;
BAUMGARTEN, C ;
PIPKORN, U .
ALLERGY, 1991, 46 (07) :540-546